In human malignancies, Axl was originally identified as an oncogene responsible for malignant transformation in chronic myeloid leukemia, in which increasing Axl expression and Axl/Gas6 interaction sufficiently led to tumorigenesis [12]. This evidence concerns the gene AXL and chronic myelogenous leukemia, BCR-ABL1 positive.